NCT04081584

Brief Summary

This study is being conducted to study light scattering properties of maternal-fetal tissue.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 3, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 9, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2021

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 8, 2021

Completed
Last Updated

August 11, 2021

Status Verified

August 1, 2021

Enrollment Period

1.9 years

First QC Date

September 3, 2019

Last Update Submit

August 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Optical signal from maternal and fetal tissues

    The study of light scattering through maternal/fetal tissue and through maternal tissue alone and newborn tissue alone using a commercial frequency domain oximeter and 2nd generation prototype.

    Peri-operative

Interventions

The ISS Device (commercial and prototype) is used to measure tissue light scattering.

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen undergoing a C-Section
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with singleton pregnancies of 36 weeks gestation or more undergoing c-section.

You may qualify if:

  • Pregnant women with singleton pregnancies, vertex or breech presentation, scheduled for non-emergent cesarean delivery, including cesarean delivery for failure to progress with reassuring electronic fetal heart rate tracing
  • Age greater than or equal to 18 years of age.
  • Healthy women at equal to or greater than 36 weeks gestation undergoing non-emergency cesarean delivery
  • Spinal or epidural anesthesia

You may not qualify if:

  • Emergency cesarian delivery
  • Non-reassuring fetal heart rate tracing
  • Less than 18 years of age
  • Multiple gestation (twins, triplets)
  • Presentation other than vertex or breech
  • Less than 36 weeks of gestation
  • General anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts Medical Center

Boston, Massachusetts, 02111, United States

Location

MeSH Terms

Conditions

Fetal Distress

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2019

First Posted

September 9, 2019

Study Start

July 1, 2019

Primary Completion

May 20, 2021

Study Completion

June 8, 2021

Last Updated

August 11, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations